Helix BioMedix, Inc. specializes in the discovery and development of bioactive peptides, which are short chains of amino acids that play crucial roles in various biological functions. The company has established a proprietary library of diverse peptides, focusing on their applications in treating rare dermatological diseases and enhancing skin health. Their innovative approach involves identifying specific peptides that can stimulate key cellular processes and bolster the skin's natural defenses. This technology is leveraged in the development of advanced cosmeceutical products, which are utilized by leading skincare companies to deliver high-performance solutions to consumers.

Among the notable peptides developed by Helix BioMedix are Oligopeptide-10, which enhances natural defense systems and shows efficacy against acne-causing bacteria, and Palmitoyl Hexapeptide-14, known for its ability to stimulate collagen production and improve skin texture. Other peptides, such as Tetrapeptide-14 and Tetrapeptide-16, are designed to mitigate inflammatory responses associated with skin conditions like rosacea and atopic dermatitis. The company’s commitment to research and development has positioned it as a leader in peptide technology, providing effective ingredients that address various skin concerns while promoting overall skin health.

United States

Helix BioMedix develops bioactive peptides based on specific natural cellular sequences for targeted topical efficacy. Our extensive library of proprietary peptide sequences can be used to treat a growing range of dermatological conditions including acne, rosacea, fungus and MRSA. Our mission is to enrich clinical practice and patient/consumer well being by developing topically-applied products which offer the health, beauty and safety benefits of our advanced bioactive small molecule peptide technology.

Helix BioMedix

Company Details